|
GEMIN5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.06040000003027E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.56419999997048E-06 |
| Normal-vs-Stage2 |
4.565800E-02 |
| Normal-vs-Stage3 |
1.63323999999854E-05 |
| Normal-vs-Stage4 |
1.66444999999404E-05 |
| Stage1-vs-Stage2 |
1.988010E-01 |
| Stage1-vs-Stage3 |
6.080600E-01 |
| Stage1-vs-Stage4 |
4.995600E-01 |
| Stage2-vs-Stage3 |
1.094980E-01 |
| Stage2-vs-Stage4 |
1.186360E-01 |
| Stage3-vs-Stage4 |
8.719400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.77969999998395E-06 |
| Normal-vs-AfricanAmerican |
1.934220E-02 |
| Normal-vs-Asian |
9.59900000000458E-05 |
| Caucasian-vs-AfricanAmerican |
5.744400E-01 |
| Caucasian-vs-Asian |
6.170400E-01 |
| AfricanAmerican-vs-Asian |
3.796200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.5497000000495E-06 |
| Normal-vs-Female |
3.39130000004406E-06 |
| Male-vs-Female |
4.438600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.01490000001559E-06 |
| Normal-vs-Age(41-60Yrs) |
3.63300000000288E-05 |
| Normal-vs-Age(61-80Yrs) |
6.27500000000003E-05 |
| Normal-vs-Age(81-100Yrs) |
6.887800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.241600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.391200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.967400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.990600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.283600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.646600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.415600E-02 |
| Classical-VS-Follicular |
5.754100E-02 |
| Classical-VS-Other |
9.666200E-02 |
| Classical-VS-Normal |
1.193680E-04 |
| Tall-VS-Follicular |
4.801200E-01 |
| Tall-VS-Other |
5.609200E-01 |
| Tall-VS-Normal |
3.59159999999692E-05 |
| Follicular-VS-Other |
3.840000E-01 |
| Follicular-VS-Normal |
3.78149999999966E-05 |
| Other-VS-Normal |
4.218400E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.75460000000549E-05 |
| Normal-vs-N1 |
1.93909999945951E-07 |
| N0-vs-N1 |
5.207800E-02 |
|
|
